Merck
MRK
$130.72
Share price
2.93%
Change (1 day)
12.18%
Change (1 year)
Categories
Operating Margin for Merck (MRK)
Operating Margin as of April 2024 (TTM): 27.73%
According to Merck's latest financial reports and stock price the company's current Operating Margin is 27.73%. At the end of 2022 the company had an Operating Margin of 27.74%.
Operating Margin history for Merck from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 27.74% | -2.66% |
| 2021 | 28.50% | 55.58% |
| 2020 | 18.32% | -25.16% |
| 2019 | 24.47% | 18.97% |
| 2018 | 20.57% | 22.34% |
| 2017 | 16.82% | -10.73% |
| 2016 | 18.84% | 37.77% |
| 2015 | 13.67% | -66.58% |
| 2014 | 40.92% | 224.94% |
| 2013 | 12.59% | -35.53% |
| 2012 | 19.53% | 27.96% |
| 2011 | 15.26% | 324.66% |
| 2010 | 3.59% | -93.55% |
| 2009 | 55.75% | 35.58% |
| 2008 | 41.12% | 195.21% |
| 2007 | 13.93% | -49.32% |
| 2006 | 27.48% | -17.84% |
| 2005 | 33.45% | -3.77% |
| 2004 | 34.76% | -13.64% |
| 2003 | 40.25% | 104.12% |
| 2002 | 19.72% | -9.54% |
| 2001 | 21.80% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -17.49% | 🇺🇸 USA |
 Novartis NVS | 17.27% | -37.72% | 🇨🇭 Switzerland |
 Pfizer PFE | 34.61% | 24.81% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -43.74% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -11.07% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 24.74% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -34.33% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 19.24% | -30.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | -18.72% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -20.53% | -174.04% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.